Marianne Ewertz1, Kaare Christensen2,3, Gerda Engholm4, Anne Mette T Kejs4, Lars Lund5, Lars E Matzen6, Per Pfeiffer1, Hans H Storm4, Jørn Herrstedt1. 1. a Department of Oncology , Odense University Hospital, Institute of Clinical Research, University of Southern Denmark , Odense , Denmark ; 2. b The Danish Aging Research Center, Department of Epidemiology, Biostatistics and Biodemography , Institute of Public Health, University of Southern Denmark , Odense , Denmark ; 3. c Department of Clinical Genetics , Odense University Hospital, and Department of Clinical Biochemistry and Pharmacology, Odense University Hospital , Odense , Denmark ; 4. d Department of Documentation & Quality , Danish Cancer Society , Copenhagen , Denmark ; 5. e Department of Urology , Odense University Hospital, Institute of Clinical Research, University of Southern Denmark , Odense , Denmark ; 6. f Geriatric Department , Odense University Hospital , Odense , Denmark.
Abstract
BACKGROUND: Age is the strongest risk factor for developing cancer. The aim of the present analysis is to give an overview of the trends in cancer incidence, mortality, prevalence, and relative survival in Denmark from 1980 to 2012 focusing on age, comparing persons aged 70 years or more with those aged less than 70 years. MATERIAL AND METHODS: Data derived from the NORDCAN database with comparable data on cancer incidence, mortality, prevalence and relative survival in the Nordic countries. The Danish data originate from the Danish Cancer Registry and the Danish Cause of Death Registry with follow-up for death or emigration until the end of 2013. RESULTS: Incidence and mortality rates of all sites, but non-melanoma skin cancer, were higher and relative survival was lower among persons aged 70 years or more than those aged less than 70 years. The age distribution (age group-specific percentages of total number of incident cases) remained constant over time while the percentage of persons dying from cancer decreased with time up to the age of 79 years but increased for those aged 80 years or more, in whom about a third of all cancer deaths occurred in 2012. In 2003-2007, the five-year relative survival was 48% for men aged 70-79 years, 38% for men aged 80-89 years, and 29% for men aged 90 years or more and the corresponding figures for women were 46%, 39%, and 36%, respectively. There was a substantial increase in the number of prevalent cancer cases aged 70 years or older, especially among those aged 90 years or more. CONCLUSION: An increase in elderly cancer patients is expected over the coming 20 years due to an increasing elderly population. Healthcare providers need to focus on developing specific strategies for treatment of elderly cancer patients in the future.
BACKGROUND: Age is the strongest risk factor for developing cancer. The aim of the present analysis is to give an overview of the trends in cancer incidence, mortality, prevalence, and relative survival in Denmark from 1980 to 2012 focusing on age, comparing persons aged 70 years or more with those aged less than 70 years. MATERIAL AND METHODS: Data derived from the NORDCAN database with comparable data on cancer incidence, mortality, prevalence and relative survival in the Nordic countries. The Danish data originate from the Danish Cancer Registry and the Danish Cause of Death Registry with follow-up for death or emigration until the end of 2013. RESULTS: Incidence and mortality rates of all sites, but non-melanoma skin cancer, were higher and relative survival was lower among persons aged 70 years or more than those aged less than 70 years. The age distribution (age group-specific percentages of total number of incident cases) remained constant over time while the percentage of persons dying from cancer decreased with time up to the age of 79 years but increased for those aged 80 years or more, in whom about a third of all cancer deaths occurred in 2012. In 2003-2007, the five-year relative survival was 48% for men aged 70-79 years, 38% for men aged 80-89 years, and 29% for men aged 90 years or more and the corresponding figures for women were 46%, 39%, and 36%, respectively. There was a substantial increase in the number of prevalent cancer cases aged 70 years or older, especially among those aged 90 years or more. CONCLUSION: An increase in elderly cancerpatients is expected over the coming 20 years due to an increasing elderly population. Healthcare providers need to focus on developing specific strategies for treatment of elderly cancerpatients in the future.
Authors: Shantell C Nolen; Marcella A Evans; Avital Fischer; Maria M Corrada; Claudia H Kawas; Daniela A Bota Journal: Mech Ageing Dev Date: 2017-05-11 Impact factor: 5.432
Authors: Young-Jae Hwang; Seon Mee Park; Soomin Ahn; Jong-Chan Lee; Young Soo Park; Nayoung Kim Journal: World J Gastroenterol Date: 2019-10-07 Impact factor: 5.742
Authors: Sidse Ehmsen; Anders Asmussen; Stefan S Jeppesen; Anna Christine Nilsson; Sabina Østerlev; Hanne Vestergaard; Ulrik S Justesen; Isik S Johansen; Henrik Frederiksen; Henrik J Ditzel Journal: Cancer Cell Date: 2021-07-27 Impact factor: 31.743
Authors: Mateusz Szewczyk; Jakub Pazdrowski; Paweł Golusiński; Aleksandra Dańczak-Pazdrowska; Mariola Pawlaczyk; Jacek Sygut; Andrzej Marszałek; Wojciech Golusiński Journal: Postepy Dermatol Alergol Date: 2018-08-21 Impact factor: 1.837